Genetics and phenomics of thyroid hormone transport by MCT8

Molecular and Cellular Endocrinology

Volumn 322, Issue 1-2, 2010, Pages 107-113

  Friesema, Edith C H ^a   Visser, W Edward ^a   Visser, Theo J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

MCT8; Thyroid hormone transport; X linked mental retardation

Indexed keywords

3,5 DIIODOTHYROPROPIONIC ACID; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ATALUREN; LEVOTHYROXINE; LIOTHYRONINE; MONOCARBOXYLATE TRANSPORTER 8; PROPIONIC ACID; PROPYLTHIOURACIL; THYROID HORMONE; THYROXINE; UNCLASSIFIED DRUG;

ALLAN HERDON DUBLEY SYNDROME; DRUG MECHANISM; DRUG MEGADOSE; DRUG WITHDRAWAL; GENE MUTATION; GENETIC SCREENING; HETEROZYGOTE; HORMONE TRANSPORT; HUMAN; HYPERHIDROSIS; HYPOTHYROIDISM; NONHUMAN; PELIZAEUS MERZBACHER DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIDE EFFECT; TACHYCARDIA; WEIGHT REDUCTION; X LINKED MENTAL RETARDATION;

BIOLOGICAL TRANSPORT; HUMANS; MENTAL RETARDATION, X-LINKED; MONOCARBOXYLIC ACID TRANSPORTERS; PHENOTYPE; THYROID HORMONES; TRIIODOTHYRONINE;

EID: 77952876422     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.01.016     Document Type: Review

References (67)

1. Abe T., Suzuki T., Unno M., Tokui T., Ito S. Thyroid hormone transporters: recent advances. Trends Endocrinol. Metab. 2002, 13:215-220.
2. Alkemade A., Friesema E.C., Unmehopa U.A., Fabriek B.O., Kuiper G.G., Leonard J.L., Wiersinga W.M., Swaab D.F., Visser T.J., Fliers E. Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus. J. Clin. Endocrinol. Metab. 2005, 90:4322-4334.
3. Allan W., Herndon C.N., Dudley F.C. Some examples of the inheritance of mental deficiency: apparently sex-linked idiocy and microcephaly. Am. J. Mental Defic. 1944, 48:325-334.
4. Bassett J.H., Harvey C.B., Williams G.R. Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol. Cell Endocrinol. 2003, 213:1-11.
5. Biebermann H., Ambrugger P., Tarnow P., von Moers A., Schweizer U., Grueters A. Extended clinical phenotype, endocrine investigations and functional studies of a loss-of-function mutation A150V in the thyroid hormone specific transporter MCT8. Eur. J. Endocrinol. 2005, 153:359-366.
6. Ceballos A., Belinchon M.M., Sanchez-Mendoza E., Grijota-Martinez C., Dumitrescu A.M., Refetoff S., Morte B., Bernal J. Importance of monocarboxylate transporter 8 for the blood-brain barrier-dependent availability of 3,5,3'-triiodo-l-thyronine. Endocrinology 2009, 150:2491-2496.
7. Chiurazzi P., Schwartz C.E., Gecz J., Neri G. XLMR genes: update 2007. Eur. J. Hum. Genet. 2008, 16:422-434.
8. de Brouwer A.P., Yntema H.G., Kleefstra T., Lugtenberg D., Oudakker A.R., de Vries B.B., van Bokhoven H., Van Esch H., Frints S.G., Froyen G., Fryns J.P., Raynaud M., Moizard M.P., Ronce N., Bensalem A., Moraine C., Poirier K., Castelnau L., Saillour Y., Bienvenu T., Beldjord C., des Portes V., Chelly J., Turner G., Fullston T., Gecz J., Kuss A.W., Tzschach A., Jensen L.R., Lenzner S., Kalscheuer V.M., Ropers H.H., Hamel B.C. Mutation frequencies of X-linked mental retardation genes in families from the EuroMRX consortium. Hum. Mutat. 2007, 28:207-208.
9. de Escobar G.M., Obregon M.J., del Rey F.E. Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract. Res. Clin. Endocrinol. Metab. 2004, 18:225-248.
10. de Menezes-Filho H.C., Radonsky V., Marui S., Brust E.S., Kuperman H., Manna T.D., Dichtchekenian V., Setian N. ESPE 2009, New York 2009.
11. Di Cosmo C., Liao X.H., Dumitrescu A.M., Weiss R.E., Refetoff S. A thyroid hormone analog with reduced dependence on the monocarboxylate transporter 8 for tissue transport. Endocrinology 2009, 150:4450-4458.
12. Dumitrescu A.M., Liao X.H., Best T.B., Brockmann K., Refetoff S. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am. J. Hum. Genet. 2004, 74:168-175.
13. Dumitrescu A.M., Liao X.H., Weiss R.E., Millen K., Refetoff S. Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. Endocrinology 2006, 147:4036-4043.
14. Friesema E.C., Docter R., Moerings E.P., Stieger B., Hagenbuch B., Meier P.J., Krenning E.P., Hennemann G., Visser T.J. Identification of thyroid hormone transporters. Biochem. Biophys. Res. Commun. 1999, 254:497-501.
15. Friesema E.C., Docter R., Moerings E.P., Verrey F., Krenning E.P., Hennemann G., Visser T.J. Thyroid hormone transport by the heterodimeric human system l amino acid transporter. Endocrinology 2001, 142:4339-4348.
16. Friesema E.C., Ganguly S., Abdalla A., Manning Fox J.E., Halestrap A.P., Visser T.J. Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J. Biol. Chem. 2003, 278:40128-40135.
17. Friesema E.C., Grueters A., Biebermann H., Krude H., von Moers A., Reeser M., Barrett T.G., Mancilla E.E., Svensson J., Kester M.H., Kuiper G.G., Balkassmi S., Uitterlinden A.G., Koehrle J., Rodien P., Halestrap A.P., Visser T.J. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 2004, 364:1435-1437.
18. Friesema E.C., Jansen J., Jachtenberg J.W., Visser W.E., Kester M.H., Visser T.J. Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Mol. Endocrinol. 2008, 22:1357-1369.
19. Friesema E.C., Jansen J., Milici C., Visser T.J. Thyroid hormone transporters. Vitam. Horm. 2005, 70:137-167.
20. Friesema E.C., Kersseboom S., Visser W.E., Klootwijk W., Visser T.J. ETA 2009, Lisbon 2009.
21. Friesema E.C., Kuiper G.G., Jansen J., Visser T.J., Kester M.H. Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism. Mol. Endocrinol. 2006, 20:2761-2772.
22. Frints S.G., Lenzner S., Bauters M., Jensen L.R., Van Esch H., des Portes V., Moog U., Macville M.V., van Roozendaal K., Schrander-Stumpel C.T., Tzschach A., Marynen P., Fryns J.P., Hamel B., van Bokhoven H., Chelly J., Beldjord C., Turner G., Gecz J., Moraine C., Raynaud M., Ropers H.H., Froyen G., Kuss A.W. MCT8 mutation analysis and identification of the first female with Allan-Herndon-Dudley syndrome due to loss of MCT8 expression. Eur. J. Hum. Genet. 2008, 16:1029-1037.
23. Gereben B., Zavacki A.M., Ribich S., Kim B.W., Huang S.A., Simonides W.S., Zeold A., Bianco A.C. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr. Rev. 2008, 29:898-938.
24. Hagenbuch B. Cellular entry of thyroid hormones by organic anion transporting polypeptides. Best Pract. Res. Clin. Endocrinol. Metab. 2007, 21:209-221.
25. Henneke M., Combes P., Diekmann S., Bertini E., Brockmann K., Burlina A.P., Kaiser J., Ohlenbusch A., Plecko B., Rodriguez D., Boespflug-Tanguy O., Gartner J. GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease. Neurology 2008, 70:748-754.
26. Hennemann G., Docter R., Friesema E.C., de Jong M., Krenning E.P., Visser T.J. Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr. Rev. 2001, 22:451-476.
27. Hermann T. Aminoglycoside antibiotics: old drugs and new therapeutic approaches. Cell Mol. Life Sci. 2007, 64:1841-1852.
28. Herzovich V., Vaiani E., Marino R., Dratler G., Lazzati J.M., Tilitzky S., Ramirez P., Iorcansky S., Rivarola M.A., Belgorosky A. Unexpected peripheral markers of thyroid function in a patient with a novel mutation of the MCT8 thyroid hormone transporter gene. Horm. Res. 2007, 67:1-6.
29. Heuer H., Maier M.K., Iden S., Mittag J., Friesema E.C., Visser T.J., Bauer K. The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology 2005, 146:1701-1706.
30. Holden K.R., Zuniga O.F., May M.M., Su H., Molinero M.R., Rogers R.C., Schwartz C.E. X-linked MCT8 gene mutations: characterization of the pediatric neurologic phenotype. J. Child Neurol. 2005, 20:852-857.
31. Jansen J., Friesema E.C., Kester M.H., Milici C., Reeser M., Gruters A., Barrett T.G., Mancilla E.E., Svensson J., Wemeau J.L., Busi da Silva Canalli M.H., Lundgren J., McEntagart M.E., Hopper N., Arts W.F., Visser T.J. Functional analysis of monocarboxylate transporter 8 mutations identified in patients with X-linked psychomotor retardation and elevated serum triiodothyronine. J. Clin. Endocrinol. Metab. 2007, 92:2378-2381.
32. Jansen J., Friesema E.C., Kester M.H., Schwartz C.E., Visser T.J. Genotype-phenotype relationship in patients with mutations in thyroid hormone transporter MCT8. Endocrinology 2008, 149:2184-2190.
33. Kakinuma H., Itoh M., Takahashi H. A novel mutation in the monocarboxylate transporter 8 gene in a boy with putamen lesions and low free T4 levels in cerebrospinal fluid. J. Pediatr. 2005, 147:552-554.
34. Kellermayer R. Translational readthrough induction of pathogenic nonsense mutations. Eur. J. Med. Genet. 2006, 49:445-450.
35. Kerem E., Hirawat S., Armoni S., Yaakov Y., Shoseyov D., Cohen M., Nissim-Rafinia M., Blau H., Rivlin J., Aviram M., Elfring G.L., Northcutt V.J., Miller L.L., Kerem B., Wilschanski M. Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. Lancet 2008, 372:719-727.
36. Kinne A., Roth S., Biebermann H., Kohrle J., Gruters A., Schweizer U. Surface translocation and tri-iodothyronine uptake of mutant MCT8 proteins are cell type-dependent. J. Mol. Endocrinol. 2009, 43:263-271.
37. Kinne A., Roth S., Schweizer U., Kohrle J. Transport activities and plasma membrane localization of MCT8 mutant proteins identified in patients with severe psychomotor retardation depend on cell type. Implications for the interpretation of clinical phenotypes. European Congress of Endocrinology. Endocr. Abstr. 2009, P573.
38. Lafreniere R.G., Carrel L., Willard H.F. A novel transmembrane transporter encoded by the XPCT gene in Xq13.2. Hum. Mol. Genet. 1994, 3:1133-1139.
39. Lechan R.M., Fekete C. Infundibular tanycytes as modulators of neuroendocrine function: hypothetical role in the regulation of the thyroid and gonadal axis. Acta Biomed. 2007, 78(Suppl. (1)):84-98.
40. Maranduba C.M., Friesema E.C., Kok F., Kester M.H., Jansen J., Sertie A.L., Passos-Bueno M.R., Visser T.J. Decreased cellular uptake and metabolism in Allan-Herndon-Dudley syndrome (AHDS) due to a novel mutation in the MCT8 thyroid hormone transporter. J. Med. Genet. 2006, 43:457-460.
41. Mariotti S., Boccone L., Dessi V., Meloni A., Loudianos G. ETA 2009, Lisbon 2009.
42. Namba N., Etani Y., Kitaoka T., Nakamoto Y., Nakacho M., Bessho K., Miyoshi Y., Mushiake S., Mohri I., Arai H., Taniike M., Ozono K. Clinical phenotype and endocrinological investigations in a patient with a mutation in the MCT8 thyroid hormone transporter. Eur. J. Pediatr. 2008, 167:785-791.
43. Namba N., Mohri I., Abe S., Kitaoka T., Miura K., Hirai H., Kitai Y., Sakai N., Taniike M., Ozono K. ENDO 2009, Washington 2009.
44. Nishimura M., Naito S. Tissue-specific mRNA expression profiles of human solute carrier transporter superfamilies. Drug Metab. Pharmacokinet. 2008, 23:22-44.
45. Papadimitriou A., Dumitrescu A.M., Papavasiliou A., Fretzayas A., Nicolaidou P., Refetoff S. A novel monocarboxylate transporter 8 gene mutation as a cause of severe neonatal hypotonia and developmental delay. Pediatrics 2008, 121:e199-202.
46. Pizzagalli F., Hagenbuch B., Stieger B., Klenk U., Folkers G., Meier P.J. Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter. Mol. Endocrinol. 2002, 16:2283-2296.
47. Price N.T., Jackson V.N., Halestrap A.P. Cloning and sequencing of four new mammalian monocarboxylate transporter (MCT) homologues confirms the existence of a transporter family with an ancient past. Biochem. J. 1998, 329(Pt 2):321-328.
48. Raymond L., Whibley A., Price S., Rosser E., Rahman N., Holder S., Stewart F., RTarpey P., Futreal A., Stratton M., Gold I. ESHG 2008, Barcelona 2008, pp. 60.
49. Rechsteiner M., Rogers S.W. PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 1996, 21:267-271.
50. Roberts L.M., Woodford K., Zhou M., Black D.S., Haggerty J.E., Tate E.H., Grindstaff K.K., Mengesha W., Raman C., Zerangue N. Expression of the thyroid hormone transporters monocarboxylate transporter-8 (SLC16A2) and organic ion transporter-14 (SLCO1C1) at the blood-brain barrier. Endocrinology 2008, 149:6251-6261.
51. Rovet J.F. Congenital hypothyroidism: an analysis of persisting deficits and associated factors. Child Neuropsychol. 2002, 8:150-162.
52. Schwartz C.E., May M.M., Carpenter N.J., Rogers R.C., Martin J., Bialer M.G., Ward J., Sanabria J., Marsa S., Lewis J.A., Echeverri R., Lubs H.A., Voeller K., Simensen R.J., Stevenson R.E. Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. Am. J. Hum. Genet. 2005, 77:41-53.
53. Sijens P.E., Rodiger L.A., Meiners L.C., Lunsing R.J. 1H magnetic resonance spectroscopy in monocarboxylate transporter 8 gene deficiency. J. Clin. Endocrinol. Metab. 2008, 93:1854-1859.
54. Sugiyama D., Kusuhara H., Taniguchi H., Ishikawa S., Nozaki Y., Aburatani H., Sugiyama Y. Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood-brain barrier: high affinity transporter for thyroxine. J. Biol. Chem. 2003, 278:43489-43495.
55. Suzuki T., Abe T. Thyroid hormone transporters in the brain. Cerebellum 2008, 7:75-83.
56. Tohyama K., Kusuhara H., Sugiyama Y. Involvement of multispecific organic anion transporter. Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. Endocrinology 2004, 145:4384-4391.
57. Trajkovic M., Visser T.J., Mittag J., Horn S., Lukas J., Darras V.M., Raivich G., Bauer K., Heuer H. Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. J. Clin. Invest. 2007, 117:627-635.
58. Uhlenberg B., Schuelke M., Ruschendorf F., Ruf N., Kaindl A.M., Henneke M., Thiele H., Stoltenburg-Didinger G., Aksu F., Topaloglu H., Nurnberg P., Hubner C., Weschke B., Gartner J. Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. Am. J. Hum. Genet. 2004, 75:251-260.
59. van der Deure W.M., Hansen P.S., Peeters R.P., Kyvik K.O., Friesema E.C., Hegedus L., Visser T.J. Thyroid hormone transport and metabolism by organic anion transporter 1C1 and consequences of genetic variation. Endocrinology 2008, 149:5307-5314.
60. van der Putten H.H., Friesema E.C., Abumrad N.A., Everts M.E., Visser T.J. Thyroid hormone transport by the rat fatty acid translocase. Endocrinology 2003, 144:1315-1323.
61. Vaurs-Barriere C., Deville M., Sarret C., Giraud G., Des Portes V., Prats-Vinas J.M., De Michele G., Dan B., Brady A.F., Boespflug-Tanguy O., Touraine R. Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects. Ann. Neurol. 2009, 65:114-118.
62. Visser W.E., Friesema E.C., Jansen J., Visser T.J. Thyroid hormone transport in and out of cells. Trends Endocrinol. Metab. 2008, 19:50-56.
63. Visser W.E., Jansen J., Friesema E.C., Kester M.H., Mancilla E., Lundgren J., van der Knaap M.S., Lunsing R.J., Brouwer O.F., Visser T.J. Novel pathogenic mechanism suggested by ex vivo analysis of MCT8 (SLC16A2) mutations. Hum. Mutat. 2009, 30:29-38.
64. Wemeau J.L., Pigeyre M., Proust-Lemoine E., d'Herbomez M., Gottrand F., Jansen J., Visser T.J., Ladsous M. Beneficial effects of propylthiouracil plus L-thyroxine treatment in a patient with a mutation in MCT8. J. Clin. Endocrinol. Metab. 2008, 93:2084-2088.
65. Wirth E.K., Roth S., Blechschmidt C., Holter S.M., Becker L., Racz I., Zimmer A., Klopstock T., Gailus-Durner V., Fuchs H., Wurst W., Naumann T., Brauer A., de Angelis M.H., Kohrle J., Gruters A., Schweizer U. Neuronal 3',3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome. J. Neurosci. 2009, 29:9439-9449.
66. Wood T., Hobson D., Browning B., Rogers C., Skinner C., Ardinger C.C., Collins C.A.A., Friez M.J., Schwartz C.E. ESHG 2008, Barcelona 2008, pp. 26.
67. Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 2001, 81:1097-1142.